CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-20 | Lian Brian President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −166,130 | 65,000 | ||
| 2024-08-21 | Lian Brian President & CEO | Option exercise 10b5-1 | +1,000 | $7.77 | $8K | 2,355,927 |
| 2024-08-21 | Lian Brian President & CEO | Sale 10b5-1 | −1,000 | $69.90 | $70K | 2,354,927 |
| 2024-08-21 | Lian Brian President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,000 | 231,130 | ||
| 2024-08-21 | SINGLETON J MATTHEW Director | Option exercise 10b5-1 | +5,700 | $1.19 | $7K | 15,200 |
| 2024-08-21 | SINGLETON J MATTHEW Director | Sale 10b5-1 | −5,700 | $69.72 | $397K | 9,500 |
| 2024-08-21 | SINGLETON J MATTHEW Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,700 | 10,300 | ||
| 2024-08-19 | Lian Brian President & CEO | Option exercise 10b5-1 | +112,870 | $7.77 | $877K | 2,467,797 |
| 2024-08-19 | Lian Brian President & CEO | Sale 10b5-1 | −70,132 | $65.33 | $4.6M | 2,397,665 |
| 2024-08-19 | Lian Brian President & CEO | Sale 10b5-1 | −31,442 | $66.37 | $2.1M | 2,366,223 |
| 2024-08-19 | Lian Brian President & CEO | Sale 10b5-1 | −11,296 | $67.12 | $758K | 2,354,927 |
| 2024-08-19 | Lian Brian President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −112,870 | 232,130 | ||
| 2024-08-19 | SINGLETON J MATTHEW Director | Option exercise 10b5-1 | +16,000 | $3.33 | $53K | 25,500 |
| 2024-08-19 | SINGLETON J MATTHEW Director | Sale 10b5-1 | −2,500 | $60.01 | $150K | 23,000 |
| 2024-08-19 | SINGLETON J MATTHEW Director | Sale 10b5-1 | −3,047 | $61.13 | $186K | 19,953 |
| 2024-08-19 | SINGLETON J MATTHEW Director | Sale 10b5-1 | −4,509 | $61.86 | $279K | 15,444 |
| 2024-08-19 | SINGLETON J MATTHEW Director | Sale 10b5-1 | −2,055 | $63.15 | $130K | 13,389 |
| 2024-08-19 | SINGLETON J MATTHEW Director | Sale 10b5-1 | −2,388 | $64.10 | $153K | 11,001 |
| 2024-08-19 | SINGLETON J MATTHEW Director | Sale 10b5-1 | −1,501 | $64.88 | $97K | 9,500 |
| 2024-08-19 | SINGLETON J MATTHEW Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,000 | 0 |
Page 7 of 27 · 528 trades